[HTML] springer.com

[HTML][HTML] Selective COX-2 inhibition affects fatty acids, but not COX mRNA expression in patients with FAP

K Almendingen, LN Larsen, O Fausa, J Bratlie… - Familial Cancer, 2010 - Springer
Familial adenomatous polyposis (FAP) provides a model for sporadic colorectal cancer
development. Cyclooxygenase (COX) inhibition may ameliorate polyp development, but …
被引用次数：11 相关文章

Selective COX-2 inhibition affects fatty acids, but not COX mRNA expression in patients with FAP

K Almendingen, LN Larsen, O Fausa, J Bratlie… - Familial Cancer, 2010 - infona.pl
Familial adenomatous polyposis (FAP) provides a model for sporadic colorectal cancer
development. Cyclooxygenase (COX) inhibition may ameliorate polyp development, but …
[PDF] psu.edu

[PDF][PDF] Selective COX-2 inhibition affects fatty acids, but not COX mRNA expression in patients with FAP

K Almendingen, LN Larsen, O Fausa, J Bratlie… - Familial Cancer, 2010 - Citeseer
Familial adenomatous polyposis (FAP) provides a model for sporadic colorectal cancer
development. Cyclooxygenase (COX) inhibition may ameliorate polyp development, but …
[PDF] oslomet.no

[PDF][PDF] Selective COX-2 inhibition affects fatty acids, but not COX mRNA expression in patients with FAP

K Almendingen, LN Larsen, O Fausa, J Bratlie… - 2010 - oda.oslomet.no
Familial adenomatous polyposis (FAP) provides a model for sporadic colorectal cancer
development. Cyclooxygenase (COX) inhibition may ameliorate polyp development, but …

Selective COX-2 inhibition affects fatty acids, but not COX mRNA expression in patients with FAP.

K Almendingen, LN Larsen, O Fausa, J Bratlie… - Familial …, 2010 - europepmc.org
Familial adenomatous polyposis (FAP) provides a model for sporadic colorectal cancer
development. Cyclooxygenase (COX) inhibition may ameliorate polyp development, but …
[PDF] core.ac.uk

[PDF][PDF] Selective COX-2 inhibition affects fatty acids, but not COX mRNA expression in patients with FAP

K Almendingen, LN Larsen, O Fausa, J Bratlie… - Familial Cancer, 2010 - core.ac.uk
Familial adenomatous polyposis (FAP) provides a model for sporadic colorectal cancer
development. Cyclooxygenase (COX) inhibition may ameliorate polyp development, but …

Selective COX-2 inhibition affects fatty acids, but not COX mRNA expression in patients with FAP

K Almendingen, LN Larsen, O Fausa, J Bratlie… - 2010 - pubmed.ncbi.nlm.nih.gov
Familial adenomatous polyposis (FAP) provides a model for sporadic colorectal cancer
development. Cyclooxygenase (COX) inhibition may ameliorate polyp development, but …
[HTML] nih.gov

[HTML][HTML] Selective COX-2 inhibition affects fatty acids, but not COX mRNA expression in patients with FAP

K Almendingen, LN Larsen, O Fausa, J Bratlie… - Familial …, 2010 - ncbi.nlm.nih.gov
Familial adenomatous polyposis (FAP) provides a model for sporadic colorectal cancer
development. Cyclooxygenase (COX) inhibition may ameliorate polyp development, but …
[PDF] cyberleninka.org

[PDF][PDF] Selective COX-2 inhibition affects fatty acids, but not COX mRNA expression in patients with FAP

K Almendingen, LN Larsen, O Fausa, J Bratlie… - Familial …, 2010 - cyberleninka.org
Familial adenomatous polyposis (FAP) provides a model for sporadic colorectal cancer
development. Cyclooxygenase (COX) inhibition may ameliorate polyp development, but …
[PDF] researchgate.net

[PDF][PDF] Selective COX-2 inhibition affects fatty acids, but not COX mRNA expression in patients with FAP

K Almendingen, LN Larsen, O Fausa, J Bratlie… - Familial …, 2010 - researchgate.net
Familial adenomatous polyposis (FAP) provides a model for sporadic colorectal cancer
development. Cyclooxygenase (COX) inhibition may ameliorate polyp development, but …